
According to quarterly, adjusted slightly in 2011 the company forecast 2013 results per share were 1.15 yuan, 1.56 yuan and 2.11 yuan, the company's current share price 25 times earnings in 2011, has been more fully reflect the company's cephalosporin products this year, the operating conditions . 2012, the company cephalosporin formulations and bulk drugs business is expected to gradually ...Salubris (002 294): reserve more abundant species
No comments:
Post a Comment